Table: Chugai Pharm -2022 group results (IFRS)

Chugai Pharmaceutical

02/02/2023 07:30

Feb 2 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2022    Dec 31, 2021   Dec 31, 2023      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales           1.26 trln        999.76                                
                 (+26.0 pct)     (+27.0 pct)                             
  Operating        533.31          421.90                                
                 (+26.4 pct)     (+40.1 pct)                             
  Pretax
  Net              374.43          303.00                                
                 (+23.6 pct)     (+41.1 pct)                             
  EPS Basic      227.64 yen      184.29 yen                              
  EPS Diluted    227.57 yen      184.17 yen                              
  Ann Div         78.00 yen       76.00 yen      80.00 yen               
  -Q2 Div         38.00 yen       30.00 yen      40.00 yen               
  -Q4 Div         40.00 yen       46.00 yen      40.00 yen               
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T